Show simple item record

dc.creatorGreen, Ronald M.en
dc.creatorDeVries, Kier Olsenen
dc.creatorBernstein, Judithen
dc.creatorGoodman, Kenneth W.en
dc.creatorKaufmann, Roberten
dc.creatorKiessling, Ann A.en
dc.creatorLevin, Susan R.en
dc.creatorMoss, Susan L.en
dc.creatorTauer, Carol A.en
dc.date.accessioned2011-07-12T18:25:20Zen
dc.date.available2011-07-12T18:25:20Zen
dc.date.created2002-05en
dc.date.issued2002-05en
dc.identifier.bibliographicCitationHastings Center Report 2002 May-June; 32(3): 27-33en
dc.identifier.urihttp://hdl.handle.net/10822/520887en
dc.descriptionACT-Advanced cell technology Glenn McGeeen
dc.description.abstractAdvanced Cell Technology's Ethics Advisory Board has been called window dressing for a corporate marketing plan. But the scientists and managers have paid attention, and the lawyers have gone along.en
dc.formatArticleen
dc.languageengen
dc.source246106en
dc.subjectCloningen
dc.subjectEthicsen
dc.subjectLawyersen
dc.subjectMarketingen
dc.subjectManagersen
dc.subjectResearchen
dc.subjectTechnologyen
dc.subject.classificationCloningen
dc.subject.classificationHuman Experimentation Policy Guidelines / Institutional Review Boardsen
dc.subject.classificationBusiness Ethicsen
dc.titleOverseeing research on therapeutic cloning: a private ethics board responds to its criticsen
dc.provenanceDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Instituteen
dc.provenanceDigital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown Universityen


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885